Search companies or stocks...
IMUImugene Limited
At close · 02 Sept 2026, 06:10 am
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Buy
Based on 1 analyst giving stock ratings to IMU in the past 3 months.
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors…
Current stock price of Imugene Limited (IMU) stock is $0.070. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Imugene Limited (IMU) stock is 1.49M.
Last updated at 02 Sept 2026, 06:10 am.
The stock price of Imugene Limited (IMU) can change with earnings, company news, and overall market sentiment. Imugene Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Imugene Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IMU on this page is -0.41. EPS on this page is -0.16. Compare those figures with peers and growth expectations before deciding if the current Imugene Limited price is justified.
Historical performance for Imugene Limited (IMU) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IMU reacted to past earnings and market events.
Buying Imugene Limited (IMU) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
